Activated CD8+ T cells in secondary progressive MS secrete lymphotoxin

Neurology. 2003 Feb 25;60(4):702-5. doi: 10.1212/01.wnl.0000048204.89346.30.

Abstract

The authors compared the functional activation state and cytokine secretion profile of CD8+ T cells in patients with relapsing-remitting and secondary progressive (SP) MS to those in normal controls. In addition, they examined cytokine secretion in relationship to single nucleotide polymorphism (SNP) analysis of cytokine genes. A significant increase in lymphotoxin secretion from anti-CD3-stimulated CD8+ T cells was observed in patients with SPMS as compared to normal controls. The authors found no significant differences in SNP frequency or in secretion of other cytokines.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Antibodies / pharmacology
  • CD3 Complex / immunology
  • CD8-Positive T-Lymphocytes / drug effects
  • CD8-Positive T-Lymphocytes / immunology*
  • CD8-Positive T-Lymphocytes / metabolism
  • Cell Division / drug effects
  • Cell Division / immunology
  • Cell Separation
  • Cells, Cultured
  • Cytokines / immunology
  • Cytokines / metabolism
  • Female
  • Flow Cytometry
  • Gene Frequency
  • Humans
  • Lymphotoxin-alpha / genetics
  • Lymphotoxin-alpha / immunology*
  • Lymphotoxin-alpha / metabolism
  • Male
  • Middle Aged
  • Multiple Sclerosis, Chronic Progressive / genetics
  • Multiple Sclerosis, Chronic Progressive / immunology*
  • Multiple Sclerosis, Relapsing-Remitting / genetics
  • Multiple Sclerosis, Relapsing-Remitting / immunology
  • Polymorphism, Single Nucleotide
  • Reference Values

Substances

  • Antibodies
  • CD3 Complex
  • Cytokines
  • Lymphotoxin-alpha